Pathology staff shortages causing delays to cancer diagnosis, says report

September 18, 2018, Cancer Research UK
Credit: CC0 Public Domain

NHS pathology departments are suffering from chronic staff shortages, finds a new report.

The workforce census by the Royal College of Pathologists revealed that just 3 in 100 departments have enough staff to meet clinical demand.

The report concludes that staff shortages are contributing to NHS delays.Experts warned that, without Government action, these vital diagnostic services "could be in jeopardy."

Histopathologists are specially trained to spot changes in cells caused by disease. They diagnose cancer and other diseases by looking at samples in a lab. Their expertise is also used to assess how aggressive a cancer is, which guides treatment.

Worrying delays

Professor Jo Martin, president of the Royal College of Pathologists, said the staff shortages are leading to worrying delays in diagnosis and treatment for cancer patients.

"For NHS hospitals, it [the shortage of staff] means spending more resources on locum doctors to fill staffing gaps, or outsourcing services," she said.

Plugging the gaps with short-term staff is estimated to cost the NHS £27m each year, according to the report. And Martin believes the money could be better invested in staff and new diagnostic equipment.

She added that demand for services has grown significantly in recent years and continues to grow. "The pathology workforce has not increased in line with this demand. If this trend continues unchecked, clinical services could be in jeopardy."

Pressures on staff

The report also highlights the pressures doctors face from increased workloads due to new developments like screening programmes and transformations in personalised medicine, which require specialised tests to match patients to drugs

The report states that 1 in 4 histopathologists are aged 55 or over and are therefore approaching retirement.

A range of solutions to help address the shortage were also proposed, including more funded training places, greater incentives to help hire trainees in hard-to-recruit areas, and improvements to IT systems to prevent delays in day-to-day work.

Emlyn Samuel, Cancer Research UK's head of policy development called for health officials to do more to protect the histopathology workforce which is vital to cancer care.

"This report is another compelling example of why the Government and NHS must address shortages in professions, like pathology, which are vital in the diagnosis and treatment of ," he said.

Explore further: Severe shortage of radiologists risks delays to cancer diagnosis, says report

Related Stories

Severe shortage of radiologists risks delays to cancer diagnosis, says report

October 12, 2017
The UK does not have enough radiologists to meet demand, according to a new report.

Tests to diagnose cancer underfunded and staff overstretched

September 7, 2015
NHS services for diagnosing cancer are underfunded, understaffed, and key waiting time targets are being missed, according to two new reports from Cancer Research UK.

To test cancer sooner, we need the government to invest in the NHS

September 2, 2015
Too many people are diagnosed with late-stage cancer each year.

Europe urged to tackle airspace bottlenecks as delays soar

July 18, 2018
The world airline body on Wednesday urged European governments to urgently fix the region's airspace bottlenecks, saying that delays had more than doubled during the first half of the year.

NHS pressures at risk of stifling cancer research, says report

May 20, 2015
Daily pressures on the NHS are having a serious impact on its ability to support world-leading research into cancer, according to a Cancer Research UK-commissioned report from the University of Birmingham.

Drug shortages pose a public health crisis in the US

June 18, 2018
On June 12, the American Medical Association announced that drug shortages pose an urgent public health crisis. This crisis should be of concern to all Americans.

Recommended for you

Successful anti-PD-1 therapy requires interaction between CD8+ T cells and dendritic cells

December 11, 2018
A team led by a Massachusetts General Hospital (MGH) investigator has found that successful cancer immunotherapy targeting the PD-1 molecule requires interaction between cytotoxic CD8+ T cells, which have been considered ...

Loss of two genes drives a deadly form of colorectal cancer, reveals a potential treatment

December 11, 2018
Colorectal cancers arise from earlier growths, called polyps, found on the inner surface of the colon. Scientists are now learning that polyps use two distinct molecular pathways as they progress to cancer, called the "conventional" ...

Taking uncertainty out of cancer prognosis

December 11, 2018
A cancer diagnosis tells you that you have cancer, but how that cancer will progress is a terrifying uncertainty for most patients. Researchers at Cold Spring Harbor Laboratory (CSHL) have now identified a specific class ...

Pushing closer to a new cancer-fighting strategy

December 11, 2018
A molecular pathway that's frequently mutated in many different forms of cancer becomes active when cells push parts of their membranes outward into bulging protrusions, Johns Hopkins researchers report in a new study. The ...

Scientists have identified and modelled a distinct biology for paediatric AML

December 11, 2018
Scientists have identified and modelled a distinct biology for paediatric acute myeloid leukaemia, one of the major causes of death in children.

HER2 mutations can cause treatment resistance in metastatic ER-positive breast cancer

December 11, 2018
Metastatic breast cancers treated with hormone therapy can become treatment-resistant when they acquire mutations in the human epidermal growth factor receptor 2 (HER2) that were not present in the original tumor, reports ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.